Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pharmacological management of patients with recurrent persistent or permanent atrial fibrillation. Pharmacological management of patients with recurrent.

Published byAlfonso Vacca Modified over 4 years ago

Similar presentations

Presentation on theme: "Pharmacological management of patients with recurrent persistent or permanent atrial fibrillation. Pharmacological management of patients with recurrent."— Presentation transcript:

1 Pharmacological management of patients with recurrent persistent or permanent atrial fibrillation.
Pharmacological management of patients with recurrent persistent or permanent atrial fibrillation. Reprinted from Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J2001;22:1852–923; by permission of the publisher W B Saunders. A Wakai, and J O O’Neill Postgrad Med J 2003;79: Copyright © The Fellowship of Postgraduate Medicine. All rights reserved.

Download ppt "Pharmacological management of patients with recurrent persistent or permanent atrial fibrillation. Pharmacological management of patients with recurrent."

Similar presentations

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for Management of Patients.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for Management of Patients.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for the Management of.

Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for the Management of.
Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.

Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.
Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.

Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.
Algorithm for guideline-directed medical therapy for patients with stable ischemic heart disease. The use of bile acid sequestrant is relatively contraindicated.

Algorithm for guideline-directed medical therapy for patients with stable ischemic heart disease. The use of bile acid sequestrant is relatively contraindicated.
Algorithm for the management of aortic valve stenosis

Algorithm for the management of aortic valve stenosis
Major recommendation for statin therapy for ASCVD prevention

Major recommendation for statin therapy for ASCVD prevention
Figure 1 Diagnostic flowchart for patients with suspected heart failure—showing alternative ‘echocardiography first’ (blue) or ‘natriuretic peptide first’

Figure 1 Diagnostic flowchart for patients with suspected heart failure—showing alternative ‘echocardiography first’ (blue) or ‘natriuretic peptide first’
American College of Cardiology Foundation/American Heart Association 2009 heart failure staging guidelines. CHF, congestive heart failure; CM, cardiomyopathy;

American College of Cardiology Foundation/American Heart Association 2009 heart failure staging guidelines. CHF, congestive heart failure; CM, cardiomyopathy;
(From Stone NJ, Robinson JG, Lichtenstein AH, et al

(From Stone NJ, Robinson JG, Lichtenstein AH, et al
From: Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American.

From: Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American.
C. ACC/AHA/ESC guidelines Role of anticoagulant therapy in AF

C. ACC/AHA/ESC guidelines Role of anticoagulant therapy in AF
 Categorisation of direct and indirect admissions to the intensive care unit (ICU) from emergency departments (EDs), using source of admission.  Categorisation.

 Categorisation of direct and indirect admissions to the intensive care unit (ICU) from emergency departments (EDs), using source of admission.  Categorisation.
Guidelines for perioperative cardiac evaluation from the American College of Cardiology/American Heart Association task force are effective for stratifying.

Guidelines for perioperative cardiac evaluation from the American College of Cardiology/American Heart Association task force are effective for stratifying.
Reproduced with permission from Yancy, C. W. et al. 2017

Reproduced with permission from Yancy, C. W. et al. 2017
Chest radiograph (A) showing confluent infiltrations of the left and right lower lobe. Chest radiograph (A) showing confluent infiltrations of the left.

Chest radiograph (A) showing confluent infiltrations of the left and right lower lobe. Chest radiograph (A) showing confluent infiltrations of the left.
Figure Photomicrograph of the lung biopsy showing a focus of interstitial pneumonitis composed of lymphocytes and macrophages with occasional eosinophils.

Figure Photomicrograph of the lung biopsy showing a focus of interstitial pneumonitis composed of lymphocytes and macrophages with occasional eosinophils.
Chest radiograph of a 60 year old man, with rheumatoid arthritis and progressive dyspnoea, showing signs of fibrosing alveolitis with basal volume loss.

Chest radiograph of a 60 year old man, with rheumatoid arthritis and progressive dyspnoea, showing signs of fibrosing alveolitis with basal volume loss.
(A) Colonic mucosa with inflammation and necrosis (× 40) and (B) at higher magnification (× 100). (A) Colonic mucosa with inflammation and necrosis (×

(A) Colonic mucosa with inflammation and necrosis (× 40) and (B) at higher magnification (× 100). (A) Colonic mucosa with inflammation and necrosis (×
A. Epidemiology update:

A. Epidemiology update:

Similar presentations

Ads by Google